Michael Kegley, Jr., the former sales director for the company that sold the purportedly performance-enhancing drug (PED) SGF-1000 that is at the heart of a years-long investigation of an international racehorse doping conspiracy, got sentenced to 30 months in prison on Thursday. Kegley, 41, had pleaded guilty in July 2021 to one count of drug adulteration and misbranding. He had admitted in open court at that time that as sales director for the Kentucky-based MediVet Equine, he sold SGF-1000 and other products to trainers and veterinarians, knowing that there was...